ES2408279R1 - Bacteria acido lactica probiotica - Google Patents

Bacteria acido lactica probiotica

Info

Publication number
ES2408279R1
ES2408279R1 ES201101353A ES201101353A ES2408279R1 ES 2408279 R1 ES2408279 R1 ES 2408279R1 ES 201101353 A ES201101353 A ES 201101353A ES 201101353 A ES201101353 A ES 201101353A ES 2408279 R1 ES2408279 R1 ES 2408279R1
Authority
ES
Spain
Prior art keywords
lactic acid
acid bacteria
probiotic lactic
bacterium
probiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201101353A
Other languages
English (en)
Other versions
ES2408279A2 (es
ES2408279B1 (es
Inventor
Ochoa Lita Sorroza
Valcarcel Fernando Real
Roman Lorena Fuentes
Arbelo Felix Acosta
Castillo Daniel Padilla
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad de las Palmas de Gran Canaria
Original Assignee
Universidad de las Palmas de Gran Canaria
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad de las Palmas de Gran Canaria filed Critical Universidad de las Palmas de Gran Canaria
Priority to ES201101353A priority Critical patent/ES2408279B1/es
Publication of ES2408279A2 publication Critical patent/ES2408279A2/es
Publication of ES2408279R1 publication Critical patent/ES2408279R1/es
Application granted granted Critical
Publication of ES2408279B1 publication Critical patent/ES2408279B1/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Cosmetics (AREA)

Abstract

Bacteria acido láctica probiótica. La presente invención se refiere a las capacidades inhibitorias de una bacteria acido láctica, de la especie Enterococcus gallinarum con un 99,7% de homología con la cepa tipo LMG 13129, y la forma en que dicha bacteria es usada, incorporada en el alimento, para tratar o prevenir la vibriosis en peces cuando es consumida.
ES201101353A 2011-12-15 2011-12-15 Bacteria acido láctica probiótica Active ES2408279B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES201101353A ES2408279B1 (es) 2011-12-15 2011-12-15 Bacteria acido láctica probiótica

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201101353A ES2408279B1 (es) 2011-12-15 2011-12-15 Bacteria acido láctica probiótica

Publications (3)

Publication Number Publication Date
ES2408279A2 ES2408279A2 (es) 2013-06-19
ES2408279R1 true ES2408279R1 (es) 2013-11-08
ES2408279B1 ES2408279B1 (es) 2014-09-09

Family

ID=48537066

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201101353A Active ES2408279B1 (es) 2011-12-15 2011-12-15 Bacteria acido láctica probiótica

Country Status (1)

Country Link
ES (1) ES2408279B1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
LT3065748T (lt) 2014-12-23 2018-03-12 4D Pharma Research Limited Bacteroides thetaiotaomicron padermė ir jos panaudojimas uždegimo sumažinimui
HUE037476T2 (hu) 2014-12-23 2018-08-28 4D Pharma Res Ltd Pirin polipeptid és immunmodulálás
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
RS59308B1 (sr) 2015-06-15 2019-10-31 4D Pharma Res Ltd Kompozicije koje sadrže bakterijske sojeve
LT3650033T (lt) 2015-06-15 2022-04-11 4D Pharma Research Limited Kompozicijos, apimančios bakterinius kamienus
EP3636272A1 (en) 2015-06-15 2020-04-15 4D Pharma Research Limited Compositions comprising bacterial strains
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
GB2561748B (en) * 2015-11-20 2019-05-08 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
TW201733601A (zh) 2016-03-04 2017-10-01 ４Ｄ製藥有限公司 包含細菌菌株之組合物
TWI802545B (zh) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
MA48940A (fr) 2017-05-22 2020-04-08 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
EP3630942B1 (en) 2017-05-24 2022-11-30 4D Pharma Research Limited Compositions comprising bacterial strain
MD3638271T2 (ro) 2017-06-14 2021-03-31 4D Pharma Res Ltd Compoziții cuprizând tulpini bacteriene
DK3804737T3 (da) 2017-06-14 2022-07-25 4D Pharma Res Ltd Sammensætninger omfattende bakteriestammer
DK3768284T3 (da) 2018-03-19 2022-03-07 4D Pharma Res Ltd Sammensætninger af enterococcus flagellin til anvendelse i terapi

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
GATESOUPE, F.-J. Updating the importance of lactic acid bacteria in fish farming: natural occurrence and probiotic treatments. Journal of Molecular Microbiology and Biotechnology. 2008, Vol. 14, Nº 1-3, páginas 107¿114. <DOI: 10.1159/000106089> *
JENNES, W., DICKS, L. M. T., VERWOERD, D. J. Enterocin 012, a bacteriocin produced by Enterococcus gallinarum isolated from the intestinal tract of ostrich. Journal of Applied Microbiology. Febrero 2000, Vol. 88, Nº 2, páginas 349-357. ISSN 1364-5072. <Doi:10.1046/j.1365-2672.2000.00979.x> *
POETA, P., COSTA, D., ROJO-BEZARES, B. et al. Detection of antimicrobial activities and bacteriocin structural genes in faecal enterococci of wild animals. Microbiological Research. Julio 2007, Vol. 162, Nº 3, páginas 257-263. ISSN 0944-5013. <Doi:10.1016/j.micres.2006.06.003> *
THEPPANGNA, W., OTSUKI, K., MURASE, T. Inhibitory effects of Enterococcus strains obtained from a probiotic product on in vitro growth of Salmonella enterica serovar enteritidis strain IFO3313. Journal of Food Protection. Septiembre 2006, Vol. 69, Nº9, páginas 2258-2262. ISSN 0362-028X. *

Also Published As

Publication number Publication date
ES2408279A2 (es) 2013-06-19
ES2408279B1 (es) 2014-09-09

Similar Documents

Publication Publication Date Title
ES2408279B1 (es) Bacteria acido láctica probiótica
AR085943A1 (es) Composicion antimicrobiana
BR112012033212A2 (pt) uso de lactobacillo inibindo a produção de gás de bactéria coliforme isolada em infantes afetados por cólica
CL2013001134A1 (es) Composicion de yogurt congelado que comprende microorganismos probioticos no replicantes .
RS54919B1 (sr) Bakterija za upotrebu kao probiotik za nutritivne i medicinske primene
BR112015024330A2 (pt) nova bactéria do ácido láctico, medicamento, alimento ou bebida, e ração que contenham a nova bactéria do ácido láctico
BR112015025256A8 (pt) Cepas probióticas para uso no tratamento ou prevenção da osteoporose
IN2012DN01638A (es)
BRPI1100666A2 (pt) Método para produzir um l-aminoácido
BRPI1011277B8 (pt) produto de bacteriocina lactobacillus pentosus, alimento e composições farmacêuticas contendo o mesmo e uso do mesmo
MX2017016283A (es) Lactobacillus paracasei para la produccion de acido linoleico conjugado, preparaciones nutricionales y farmaceuticas que lo contienen y sus usos.
RS54478B1 (en) LACTOBACILLUS PLANTARUM MCC1 DSM 23881 ISOLATED MICRO-ORGANISM AND ITS USE
EA201290623A1 (ru) Лактобациллы с антиоксидантным действием
MX2016014991A (es) Composiciones que contienen acido borico y una mezcla de lactobacilos.
CL2014001239A1 (es) Método para mejorar eficiencia del alimento o de reducir patógenos en un ave que comprende la administración al ave de un suplemento de bacterias del ácido láctico del género lactobacillus ; y composición que comprende las bacterias.
BR112017023636A2 (pt) suplemento dietético
MY171048A (en) Pharmaceutical composition for preventing or treating amyloid beta peptide-associated diseases or conditions
MX356959B (es) Cepa paenibacillus alvei ts-15 y su uso en el control de organismos patogenicos.
CL2013001313A1 (es) Composicion que comprende microorganismos probióticos no replicantes para prevenir o tratar infecciones gastrointestinales
GEP20207089B (en) Histamine-producing bacterial strains and their use in cancer
CL2013000991A1 (es) Composicion que comprende polipeptido microbiano blad o variante activo del mismo; uso de dicha composicion para matar o inhibir el crecimiento de un microorganismo que es patogeno humano o animal.
WO2011152568A8 (en) A method for producing an l-amino acid using a bacterium of the enterobacteriaceae family, having attenuated expression of genes encoding a lysine/arginine/ornithine transporter
CL2017001818A1 (es) Bacteria de ácido láctico y su uso para el tratamiento de mastitis
BR112014004123A2 (pt) micro-organismos das espécies bacteroides xylanisolvens
WO2012138477A3 (en) Probiotic bacterial strains and method of use to decrease mortality due to bacterial disease

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2408279

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20140909